JP2021070677A5 - - Google Patents

Download PDF

Info

Publication number
JP2021070677A5
JP2021070677A5 JP2019200346A JP2019200346A JP2021070677A5 JP 2021070677 A5 JP2021070677 A5 JP 2021070677A5 JP 2019200346 A JP2019200346 A JP 2019200346A JP 2019200346 A JP2019200346 A JP 2019200346A JP 2021070677 A5 JP2021070677 A5 JP 2021070677A5
Authority
JP
Japan
Prior art keywords
hinokinin
cubebin
active ingredient
hyperuricemia
prophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019200346A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021070677A (ja
JP7437731B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2019200346A priority Critical patent/JP7437731B2/ja
Priority claimed from JP2019200346A external-priority patent/JP7437731B2/ja
Publication of JP2021070677A publication Critical patent/JP2021070677A/ja
Publication of JP2021070677A5 publication Critical patent/JP2021070677A5/ja
Application granted granted Critical
Publication of JP7437731B2 publication Critical patent/JP7437731B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019200346A 2019-11-02 2019-11-02 生活習慣病の予防と治療用医薬組成物および飲食品 Active JP7437731B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019200346A JP7437731B2 (ja) 2019-11-02 2019-11-02 生活習慣病の予防と治療用医薬組成物および飲食品

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019200346A JP7437731B2 (ja) 2019-11-02 2019-11-02 生活習慣病の予防と治療用医薬組成物および飲食品

Publications (3)

Publication Number Publication Date
JP2021070677A JP2021070677A (ja) 2021-05-06
JP2021070677A5 true JP2021070677A5 (OSRAM) 2022-10-14
JP7437731B2 JP7437731B2 (ja) 2024-02-26

Family

ID=75714197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019200346A Active JP7437731B2 (ja) 2019-11-02 2019-11-02 生活習慣病の予防と治療用医薬組成物および飲食品

Country Status (1)

Country Link
JP (1) JP7437731B2 (OSRAM)

Similar Documents

Publication Publication Date Title
DK3999042T3 (da) Cannabinoidderivater som farmaceutisk aktive forbindelser og fremgangsmåder til fremstilling deraf
HK1256256A1 (zh) 包含urat1的有效抑制剂的药物组合物
MX392213B (es) Composiciones farmacéuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano.
HK1259440A1 (zh) 包含btk抑制剂的配制品/组合物
NZ749427A (en) Thiophene, manufacturing method thereof, and pharmaceutical application of same
MX2021007069A (es) 3,3-difluoroalilaminas o sales de las mismas y composiciones farmaceuticas que comprenden las mismas.
NZ745210A (en) Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor
FI3248597T3 (fi) Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen
HK1259441A1 (zh) 包含btk抑制剂的制剂/组合物
JOP20200100A1 (ar) مشتقات بيرازولو-بيرولو-بيريميدين-ديون جديدة كمثبِّطات لـ p2x3
NZ598750A (en) Therapeutic agent for mood disorders
JOP20210227A1 (ar) شكل بلوري من مونوهيدرات 1-(1-أوكسو-1، 2-داي هيدروأيزوكينولين-5-يل)-5-(تراي فلوروميثيل)-n-(2-(تراي فلوروميثيل)بيريدين-4-يل)-1h-بيرازول-4-كربوكساميد
WO2011159129A3 (ko) 신규한 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 ａｉｄｓ 예방 또는 치료용 약학 조성물
CN109661395A (zh) Pde4抑制剂
CN115666576A (zh) 一种治疗和/或预防冠状病毒引发的疾病的化合物及其应用
CO2022008616A2 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma
JP2014218523A5 (OSRAM)
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use
JP2020518547A5 (OSRAM)
MX381234B (es) Agente preventivo y/o terapéutico de enfermedad inmune.
JP2018150270A5 (OSRAM)
CO2018002046A2 (es) Nueva composición oral de libreación retardada dual de dexlansoprazol
JP2020043851A5 (OSRAM)
JPWO2022177029A5 (OSRAM)
WO2015131814A3 (zh) [(芳氧基)(杂芳基)]甲基哌啶衍生物在制备治疗抑郁症的药物中的应用